MRI-guided prostate adaptive radiotherapy – A systematic review von McPartlin, A.J, Li, X.A, Kershaw, L.E, Heide, U, Kerkmeijer, L, Lawton, C, Mahmood, U, Pos, F, van As, N, van Herk, M, Vesprini, D, van der Voort van Zyp, J, Tree, A, Choudhury, A

Volltext

UK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy von Hanna, G.G., Murray, L., Patel, R., Jain, S., Aitken, K.L., Franks, K.N., van As, N., Tree, A., Hatfield, P., Harrow, S., McDonald, F., Ahmed, M., Saran, F.H., Webster, G.J., Khoo, V., Landau, D., Eaton, D.J., Hawkins, M.A.

Volltext

UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy von Diez, P., Hanna, G.G., Aitken, K.L., van As, N., Carver, A., Colaco, R.J., Conibear, J., Dunne, E.M., Eaton, D.J., Franks, K.N., Good, J.S., Harrow, S., Hatfield, P., Hawkins, M.A., Jain, S., McDonald, F., Patel, R., Rackley, T., Sanghera, P., Tree, A., Murray, L.

Volltext

Pattern of Progression after Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Nodal Recurrences von Ost, P, Jereczek-Fossa, B.A, Van As, N, Zilli, T, Tree, A, Henderson, D, Orecchia, R, Casamassima, F, Surgo, A, Miralbell, R, De Meerleer, G

Volltext

Metastasis-directed Therapy in Prostate Cancer: Prognostic Significance of the ESTRO/EORTC Classification in Oligometastatic Bone Disease von Nicholls, L., Chapman, E., Khoo, V., Suh, Y.-e., Tunariu, N., Wang, Y., van As, N.

Volltext

Prostate Volume Changes during Extreme and Moderately Hypofractionated Magnetic Resonance Image-guided Radiotherapy von Alexander, S E, McNair, H A, Oelfke, U, Huddart, R, Murray, J, Pathmanathan, A, Patel, P, Sritharan, K, van As, N, Tree, A C

Volltext

In Reply to Onal et al von Nicholls, L, Chapman, E, Khoo, V, Suh, Y-E, van As, N

Volltext

Stereotactic Body Radiotherapy for Prostate Cancer von Henderson, D.R, Tree, A.C, van As, N.J

Volltext

Stereotactic Ablative Radiotherapy for Oligometastatic Disease: A Tale of Emperor's New Clothes or New Standard of Care? von Chapman, E.R., Correa, R.J.M., Palma, D.A., Van As, N.

Volltext

Clinical Outcomes of Stereotactic Body Radiotherapy With Immediate Versus Delayed Hormone Therapy in Men With Oligometastatic Recurrence of Prostate Cancer von Chaw, C.L., deSouza, N.M., Khoo, V., Suh, Y.E., van As, N.

Volltext

Patterns of Failure After Stereotactic Body Radiotherapy to Sacral Metastases von Ratnakumaran, R., van As, N., Khoo, V., McDonald, F., Tait, D., Ahmed, M., Taylor, H., Griffin, C., Dunne, E.M., Tree, A.C.

Volltext

Stereotactic Body Radiation Therapy Planning for Localized Prostate Cancer in the PACE Phase 3 Trial: Can This Be Done Without Fused Planning MRI? von Henderson, D.R, Tree, A, van As, N

Volltext

An Investigation of Dosimetric Correlates of Acute Toxicity in Prostate Stereotactic Body Radiotherapy: Dose to Urinary Trigone is Associated with Acute Urinary Toxicity von Henderson, D.R., Murray, J.R., Gulliford, S.L., Tree, A.C., Harrington, K.J., Van As, N.J.

Volltext

Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder von Hafeez, S, Horwich, A, Omar, O, Mohammed, K, Thompson, A, Kumar, P, Khoo, V, Van As, N, Eeles, R, Dearnaley, D, Huddart, R

Volltext

Development of UK guidance on the management of erectile dysfunction resulting from radical radiotherapy and androgen deprivation therapy for prostate cancer von White, I. D., Wilson, J., Aslet, P., Baxter, A. B., Birtle, A., Challacombe, B., Coe, J., Grover, L., Payne, H., Russell, S., Sangar, V., Van As, N., Kirby, M.

Volltext

Single Fraction External Beam Radiotherapy for Localised Prostate Cancer: a Planning Study von Henderson, D, Tree, A, van As, N

Volltext

Is Biochemical Relapse-free Survival After Profoundly Hypofractionated Radiotherapy Consistent with Current Radiobiological Models? von Tree, A.C, Khoo, V.S, van As, N.J, Partridge, M

Volltext

Initial UK Experience of Stereotactic Body Radiotherapy for Extracranial Oligometastases: Can We Change the Therapeutic Paradigm? von Aitken, K, Tree, A, Thomas, K, Nutting, C, Hawkins, M, Tait, D, Mandeville, H, Ahmed, M, Lalondrelle, S, Miah, A, Taylor, A, Ross, G, Khoo, V, van As, N

Volltext

OC-0447: Stereotactic Body Radiotherapy (SBRT) in oligometastatic prostate cancer patients von Chaw, C.L, Henderson, D, Khoo, V, Tree, A, Eeles, R, Van As, N

Volltext

Prostate Stereotactic Body Radiotherapy — First UK Experience von Tree, A.C, Ostler, P, Hoskin, P, Dankulchai, P, Nariyangadu, P, Hughes, R.J, Wells, E, Taylor, H, Khoo, V.S, van As, N.J

Volltext